首页> 外文期刊>Internal medicine journal >Hyperammonaemic encephalopathy associated with rituximab-containing chemotherapy.
【24h】

Hyperammonaemic encephalopathy associated with rituximab-containing chemotherapy.

机译:高氨血症性脑病与含利妥昔单抗的化疗有关。

获取原文
获取原文并翻译 | 示例
           

摘要

Abstract Hyperammonaemic encephalopathy has been infrequently reported after both standard and high-dose chemotherapy for solid and haematological malignancies. It is important to consider this diagnosis for patients with unexplained behaviour changes or encephalopathy and this case report emphasizes this condition and the importance of early diagnosis and is the first reported in association with rituximab-containing chemotherapy.
机译:摘要固体和血液学恶性肿瘤在标准和大剂量化疗后很少报道高氨血症性脑病。对于无法解释的行为改变或脑病的患者,考虑这种诊断很重要,该病例报告强调了这种情况和早期诊断的重要性,并且是首次与含利妥昔单抗的化疗相关的报道。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号